Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to ZHANG Mi

A case analysis of liver injury induced by gefitinib

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):111-115.
858 times 347 times

XU Pei ZHANG Mi XIONG Xin HUANG Lu

Gefitinib Liver injury Adverse drug reaction
Details
A case of pharmaceutical caring for psychiatric abnormalities associated with low dose regorafenib in the treatment of advanced soft tissue sarcoma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):466-470.
2241 times 647 times

FANG Shasha AN Wei TIAN Ying YU Qianqian ZHANG Mingwei CHEN Min

Regorafenib Soft tissue sarcoma Mental disorders Drug adverse reactions Pharmaceutical care
Details
Research status and hot trends of off-label drug use in China

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):410-421.
1492 times 1073 times

ZHANG Mingyue ZHANG Xin XU Caihua LI Yiyi LI Tengfei ZHOU Yongjia CUI Yating TIAN Jinhui

Off-label drug use Research status Hot trends Visualization Rational drug use
Details
The effect of LH level on the day of GnRH antagonist administration upon the outcomes of IVF-ET

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):588-594.
1495 times 474 times

LI Guigui WU Ying ZHANG Ming

Controlled ovarian hyperstimulation Gonadotropin releasing hormone antagonist Clinical pregnancy rate Luteinzing hormone level
Details
The neuroprotective effect of curcumin by inhibiting the aggregation of α-synuclein on lipopolysaccharide-induced Parkinson’s disease model

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):779-787.
1072 times 472 times

GAN Xiaokui SONG Xiaowei ZHANG Ming FANG Yiming MA Longbiao HUANG Baosheng

Parkinson's disease Curcumin α-synuclein Oxidative stress Neuroinflammation Lipopolysaccharide
Details
Construction of a prediction model for moderate to severe perimenopausal syndrome based on machine learning algorithms

Published on New Medicine 2024,34(8):871-879.
1055 times 298 times

ZHANG Min GU Tingting GUAN Wei LIU Xiangxiang SHI Junyao

Perimenopausal syndrome Perimenopausal women Machine learning Prediction
Details
Influencing factors of the therapeutic effect of PD-1 inhibitor pembrolizumab on cervical cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1375-1382.
873 times 184 times

HU Jinghua SANG Xuemei QIAO Wei ZHANG Miao

Programmed death-1 Programmed death-ligand 1 Pabolizumab Cervical carcinoma Tumor mutation burden Tumor infiltrating lymphocytes Neoantigen intra-tumoral heterogeneity
Details